Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

B-Cell Targeted Therapy for Acute Renal Allograft Rejection With an Antibody Mediated Component: A Prospective, Randomized, Open-Label Study

NCT00771875 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

NCT NCT00771875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00771875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
B-Cell Targeted Therapy for Acute Renal Allograft Rejection With an Antibody Mediated Component: A Prospective, Randomized, Open-Label Study
Lead sponsor
University of Cincinnati
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2008
Completion date
March 31, 2013
Enrollment
30 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

graft rejection